ATE339420T1 - Neue verbindungen - Google Patents

Neue verbindungen

Info

Publication number
ATE339420T1
ATE339420T1 AT01981286T AT01981286T ATE339420T1 AT E339420 T1 ATE339420 T1 AT E339420T1 AT 01981286 T AT01981286 T AT 01981286T AT 01981286 T AT01981286 T AT 01981286T AT E339420 T1 ATE339420 T1 AT E339420T1
Authority
AT
Austria
Prior art keywords
new connections
substituted
triazolo
pyrimidines
medicaments
Prior art date
Application number
AT01981286T
Other languages
English (en)
Inventor
Simon Guile
Barrie Martin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE339420T1 publication Critical patent/ATE339420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
AT01981286T 2000-11-09 2001-11-07 Neue verbindungen ATE339420T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004098A SE0004098D0 (sv) 2000-11-09 2000-11-09 Novel compounds

Publications (1)

Publication Number Publication Date
ATE339420T1 true ATE339420T1 (de) 2006-10-15

Family

ID=20281755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981286T ATE339420T1 (de) 2000-11-09 2001-11-07 Neue verbindungen

Country Status (10)

Country Link
US (2) US6844348B2 (de)
EP (1) EP1335918B1 (de)
JP (1) JP4190282B2 (de)
AT (1) ATE339420T1 (de)
AU (1) AU2002212941A1 (de)
DE (1) DE60123103T2 (de)
ES (1) ES2271083T3 (de)
HK (1) HK1056361A1 (de)
SE (1) SE0004098D0 (de)
WO (1) WO2002038571A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004107A1 (en) * 2004-07-02 2006-01-05 Masanori Ojima Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same
DE102008002471A1 (de) * 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (es) * 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos

Also Published As

Publication number Publication date
ES2271083T3 (es) 2007-04-16
US20050143399A1 (en) 2005-06-30
JP2004513173A (ja) 2004-04-30
US7345047B2 (en) 2008-03-18
JP4190282B2 (ja) 2008-12-03
EP1335918A1 (de) 2003-08-20
DE60123103D1 (de) 2006-10-26
HK1056361A1 (en) 2004-02-13
SE0004098D0 (sv) 2000-11-09
DE60123103T2 (de) 2007-03-15
AU2002212941A1 (en) 2002-05-21
WO2002038571A1 (en) 2002-05-16
US20040029899A1 (en) 2004-02-12
EP1335918B1 (de) 2006-09-13
US6844348B2 (en) 2005-01-18

Similar Documents

Publication Publication Date Title
TR200000197T2 (tr) Yeni bileşimler
DE69804964T2 (de) Neue verbindungen
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ATE403657T1 (de) Chemische verbindungen
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
CY1113047T1 (el) Νεα κρυσταλλικη και αμορφη μορφη μιας ενωσης τριαζολο (4,5-d) πυριμιδινης
WO2003095455A3 (en) Substituted pyrazolopyrimidines
WO2002048147A3 (en) Pyrazolopyridines
WO2004074244A3 (en) Pyrimidine compounds
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
TR200000152T2 (tr) Yeni bileşikler.
WO2004106293A3 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
ATE339420T1 (de) Neue verbindungen
ATE345343T1 (de) Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds
EP1436279A4 (de) Chemische verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties